Gradient Investments LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1542265 ARDEN HILLS, MN

Position in ACAD

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$828,271

+$184,957 QoQ

Shares Held

32,738

+13.3% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#166

of 350 holders

Holding Since

Dec 2021

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gradient Investments LLC holds $2,903,408 across 4 Biotechnology names. ACAD ranks #2 (28.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	16,437	$1,286,523
2	ACAD	Acadia Pharmaceuticals Inc This page	32,738	$828,271
3	REGN	Regeneron Pharmaceuticals, Inc.	827	$515,667
4	ORKA	Oruka Therapeutics, Inc.	2,868	$272,947

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$828,271	32,738	+13.3%	Shares	Sole	2026-07-08
2026-03-31	$643,314	28,900	+33504.7%	Shares	Sole	2026-04-13
2021-12-31	$2,007	86	—	Shares	Sole	2022-01-12
No filing history on record for this holder in this stock.